GoPro (GPRO ) just released its first quarter financial results, posting an adjusted loss of $0.34 per share and revenues of $202.35 million.
GoPro is currently a Zacks Rank #3 (Hold), which is subject to change based on today’s results. Shares of GoPro have plummeted over 40% in the last year and 11.4% in the last four weeks. The action camera company also saw its stock price dip marginally on Thursday to $4.96 per share prior to the release of its quarterly earnings results.
GoPro stock is currently up 3.43% to $5.13 per share in after-hours trading shortly after its earnings report was released.
Beat earnings estimates. The company posted an adjusted loss of $0.34 per share, beating the Zacks Consensus Estimate that called for a loss of $0.40 per share.
Beat revenue estimates. The company saw revenue figures of $202.35 million, crushing our consensus estimate of $175.40 million.
GoPro’s quarterly revenues fell roughly 7% from $218.61 million in the year-ago period. Meanwhile, the action camera company’s bottom line climbed 22.7% from a $0.44 loss per share in the year-prior period.
“We began to step up marketing programs in March which, coupled with overall expense controls, solid channel management and second half new product launches, gives us confidence for a successful 2018 for GoPro,” CEO Nicholas Woodman said in a statement.
Here’s a graph that looks at GPRO’s Price, Consensus and EPS Surprise history:
GoPro, Inc. Price, Consensus and EPS Surprise
GoPro, Inc. Price, Consensus and EPS Surprise | GoPro, Inc. Quote
Check back later for our full analysis on GPRO’s earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>